Nano-x exhibiting as well. As per usual, it seems like smoke and mirrors - doesn't seem like they have anything physical to show, only a 'virtual experience'.
They claim to be ready to release a commercial product in 2022, but there is nothing but cartoons to be shown. They seem to be burning US$42M per year,
They also have a pending shareholder class action for making misleading claims about their FDA clearance status to be registered with the courts in December. I don't know what that will cost them in terms of money if the class action rules against them - seems to be around around 30% loss in share price (or 30% falsely inflated price) as a result of the allegedly false statements. It'll certainly lower the shareholder confidence though.
